Current diagnostic tools used in interstitial lung disease (ILD) do not meet the challenges set by the complex pathophysiology of this heterogenous group. The investigators therefore aimed to evaluate novel or not widely used diagnostic approaches for the detection and therapeutic monitoring of patients with various ILDs.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
lung clearance index (LCI) as determined by multiple breath washout
Timeframe: 30 minutes
airway resistance and reactance (R5, X5, R-D5-20) as determined by impulse oscillometry
Timeframe: 30 minutes